Neurophysiologic Study of Patient With Essential Tremor and Dystonic Tremor
2 other identifiers
observational
2
1 country
1
Brief Summary
Background: Essential tremor is when a person has tremor, but no other neurological symptoms. Dystonic tremor is when a person also has dystonia. Dystonia is a condition in which muscle contraction causes changes in posture. Researchers do not fully know what areas of the brain cause these tremors, or how the types differ. They also do not know what tests can identify the differences. Objective: To look at differences between essential tremor and dystonic tremor. Eligibility: People ages 18 and older with or without tremor Design: Participants will be screened with medical history, physical exam, and urine tests. Those with tremor will complete questionnaires about how tremor affects them. The screening and study visits can be done on the same day or on separate days. Participants will have 1 or 2 study visits. These include magnetic resonance imaging (MRI) and tremor testing. For MRI, participants will lie on a table that slides in and out of a cylinder that takes pictures. Sensors on the skin measure breathing, heart rate, and muscle activity. This takes about 2 hours. Tremor testing will include transcranial magnetic stimulation (TMS), electrical stimulation of the fingers, doing a movement task, and recording of tremor movements. For TMS, two wire coils will be held on the scalp and a brief magnetic field will be produced. A brief electrical current will pass through the coils. For the other tests, small sticky pad electrodes will be put on the skin. Participants will move their hand when they hear a sound. They will get weak electrical shocks to their fingers. These tests will take 3-4 hours. Participants can take part in either or both parts of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2017
CompletedFirst Posted
Study publicly available on registry
February 3, 2017
CompletedStudy Start
First participant enrolled
April 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 22, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 22, 2018
CompletedAugust 1, 2018
March 1, 2018
12 months
February 2, 2017
July 31, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The various neurophysiological results including the data from TMS experiment, tremor analysis, threshold of temporal discrimination, ballistic movement and MRI experiment. These results will be compared between HVs and patients group.
2 years
Study Arms (3)
Normal volunteers
people who are healthy and without tremor
Essential tremor
Patients with essential tremor
Dystonic tremor
patient with tremor who also have dystonia
Eligibility Criteria
Patients will be referred to NIH or may refer themselves from all over the United States.
You may qualify if:
- Tremor Subjects:
- Must be 18 years or older
- Fulfill the diagnostic criteria of essential tremor, pure dystonic tremor and tremor associated dystonia, as defined by the Consensus Statement of the Movement Disorder Society on Tremor, 1998. We will recruit patients displaying hand tremors in each group as the follows:
- Hand tremor patients in ET group.
- Dystonic hand tremor patients in pDT group.
- Cervical dystonia (CD) patients or spasmodic dysphonia and hand tremor without clinical evidence of hand dystonia in TAWD group.
- Ability to give informed consent.
- Ability to comply with all study procedures, based on the judgment by the investigator(s).
- Agree to not drink caffeine or alcohol for 48 hours before participating in the protocol.
- Healthy Volunteers:
- Must be 18 years or older
- Absence of dystonia or other neurological disorder with any effect on the motor or sensory systems.
- Ability to give informed consent.
- Ability to comply with all study procedures, based on the judgment by the investigator(s).
- Agree to not drink caffeine or alcohol for 48 hours before participating in the protocol.
You may not qualify if:
- Patients:
- Botulinum toxin treatment \< 3 months prior to visit.
- Employees and/or staff of NINDS
- Has used illegal drugs within the past 6 months based on history. The intent is to exclude those with drug use that may affect study results. Participants who appear to be intoxicated at the time of testing will be rescheduled.
- Has more than 7 alcoholic drinks a week in the case of a woman and 14 alcoholic drinks a week in the case of a man.
- Abnormal findings on neurologic exam (other than tremor and dystonia in patient group)
- Has had a brain tumor, a stroke, head trauma, epilepsy or a history of seizures.
- Has major depression or any major mental disorders (axis I disorders)
- Has a neurologic disorder other than tremor or dystonia
- Has had a head injury where there was a loss of consciousness for more than a few seconds.
- Currently taking primidone, anticholinergics or benzodiazepines.
- Healthy Volunteers:
- Employees and/or staff of NINDS
- Has used illegal drugs within the past 6 months based on history. The intent is to exclude those with drug use that may affect study results. Participants who appear to be intoxicated at the time of testing will be rescheduled.
- Has more than 7 alcoholic drinks a week in the case of a woman and 14 alcoholic drinks a week in the case of a man.
- +12 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Publications (3)
Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord. 1998;13 Suppl 3:2-23. doi: 10.1002/mds.870131303.
PMID: 9827589BACKGROUNDNi Z, Pinto AD, Lang AE, Chen R. Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol. 2010 Dec;68(6):816-24. doi: 10.1002/ana.22221.
PMID: 21194152BACKGROUNDPascual-Leone A, Valls-Sole J, Toro C, Wassermann EM, Hallett M. Resetting of essential tremor and postural tremor in Parkinson's disease with transcranial magnetic stimulation. Muscle Nerve. 1994 Jul;17(7):800-7. doi: 10.1002/mus.880170716.
PMID: 8008009BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Hallett, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2017
First Posted
February 3, 2017
Study Start
April 7, 2017
Primary Completion
March 22, 2018
Study Completion
March 22, 2018
Last Updated
August 1, 2018
Record last verified: 2018-03